Medical Research News

RSS

Quantum Imaging secures £1.6 million investment to develop medical imaging device

Quantum Imaging Ltd, a University of Leeds spin out, has secured a £1.6 million investment to develop its medical imaging technology.

8 Apr 2014

Access provides update on new formulation of anti-inflammatory drug amlexanox

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.

8 Apr 2014

Tunstall, University of Leeds and Oxford University partner to find new evidence on benefits of telecare

Tunstall Healthcare, the leading provider of technology enabled care services, has partnered with the University of Leeds and Oxford University to address the challenges arising from population ageing and the opportunities of technological progress.

8 Apr 2014

Prostate cancer breakthroughs offer new hope for men

Men have lower life expectancy than women. This discrepancy is especially pronounced for African American men who live 6 fewer years than women. According to the CDC, life expectancy in the US is 76 years for men compared to 81 for women.

8 Apr 2014

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.

8 Apr 2014

Study: VISTA deficiency leads to enhanced immune activation

Researchers at the Geisel School of Medicine at Dartmouth have found that the body's immune system response was enhanced when they disrupted VISTA, a protein that prevents the immune system from overreacting.

8 Apr 2014

Biologists find ways to address antibiotic resistance

Biologists could gain a deeper understanding about how species have evolved - and even find ways to address antibiotic resistance - using tools that were developed recently at Stockholm's KTH Royal Institute of Technology.

8 Apr 2014

Patient-friendly examination method reduces need for prostate cancer biopsies

Each year prostate tissue samples are taken from over a million men around the world - in most cases using 12 large biopsy needles - to check whether they have prostate cancer.

8 Apr 2014

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream")( TOKYO:4587) announced today, in collaboration with The Tokyo Metropolitan Institute of Medical Science ("Tokyo Metropolitan Institute") the discovery and development of a novel macrocyclic peptide inhibitor for the treatment of multiple influenza strains.

8 Apr 2014

African Americans are at higher risk of developing Alzheimer's disease than white population

A new study by researchers at Rush University Medical Center reviews research that suggests that the risk for developing Alzheimer's disease among older African Americans may be two to three times greater than in the non-Hispanic white population and that they differ from the non-Hispanic white population in risk factors and disease manifestation.

8 Apr 2014

Study: Seniors living in community with dementia are more likely to be hospitalized

Seniors living in the community who have dementia are more likely to be hospitalized and visit the emergency department than those who do not have dementia, according to a new study by researchers at RTI International.

8 Apr 2014

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Fred Hutchinson Cancer Research Center scientists striving for new cancer cures - and the patients who stand to benefit from them - got an enormous boost today when the Bezos family committed $20 million to support the development of novel cancer immunotherapies. It is the largest single contribution in Fred Hutch's history.

8 Apr 2014

Obese people take less time to feel full than those of normal weight

Obese people take less time to feel full than those of normal weight. Despite this, they consume more calories. A faster speed of eating could play an important role in obesity, according to a study funded by the Swiss National Science Foundation.

8 Apr 2014

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Researchers from the Jacks Laboratory at MIT's Koch Institute for Integrative Cancer Research (KI) have developed and characterized a genetically engineered mouse that successfully models progression from papillary thyroid cancer, which has an excellent prognosis, to anaplastic thyroid cancer (ATC), a highly lethal disease.

8 Apr 2014

Antimicrobial agent in personal care products boosts colonization of bacteria inside human noses

An antimicrobial agent found in common household soaps, shampoos and toothpastes may be finding its way inside human noses where it promotes the colonization of Staphylococcus aureus bacteria and could predispose some people to infection.

8 Apr 2014

Research to understand exactly how bleach kills bacteria

Spring cleaning often involves chlorine bleach, which has been used as a disinfectant for hundreds of years. But our bodies have been using bleach's active component, hypochlorous acid, to help clean house for millennia. As part of our natural response to infection, certain types of immune cells produce hypochlorous acid to help kill invading microbes, including bacteria.

8 Apr 2014

New injectable hydrogel repairs damaged cardiac tissue following heart attack

University of California, San Diego bioengineer Karen Christman's new injectable hydrogel, which is designed to repair damaged cardiac tissue following a heart attack, has been licensed to San Diego-based startup Ventrix, Inc, which is planning the first human clinical trials of the technology. Christman is a co-founder of Ventrix.

8 Apr 2014

Novartis Institute researcher receives second annual Andrew Carnegie Prize in Mind and Brain Sciences

Carnegie Mellon University will award the second annual Andrew Carnegie Prize in Mind and Brain Sciences to Ricardo Dolmetsch, global head of neuroscience at the Novartis Institute for Biomedical Research.

8 Apr 2014

Dream team aims to turn pancreatic cancer into treatable disease

UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.

8 Apr 2014

Researchers show Elafin protein plays key role against inflammatory reaction typical of celiac disease

Scientists from INRA and INSERM (France) in collaboration with scientists from McMaster University (Canada) and the Ecole polytechnique fédérale of Zurich (Switzerland) have shown that Elafin, a human protein, plays a key role against the inflammatory reaction typical of celiac disease (gluten intolerance).

8 Apr 2014

Medical Research News

Quantum Imaging secures £1.6 million investment to develop medical imaging device

Access provides update on new formulation of anti-inflammatory drug amlexanox

Tunstall, University of Leeds and Oxford University partner to find new evidence on benefits of telecare

Prostate cancer breakthroughs offer new hope for men

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Study: VISTA deficiency leads to enhanced immune activation

Biologists find ways to address antibiotic resistance

Patient-friendly examination method reduces need for prostate cancer biopsies

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

African Americans are at higher risk of developing Alzheimer's disease than white population

Study: Seniors living in community with dementia are more likely to be hospitalized

Bezos family gifts $20M to Fred Hutchinson scientists for development of novel cancer immunotherapies

Obese people take less time to feel full than those of normal weight

Combination therapy with MEK and BRAF inhibitors for anaplastic thyroid cancer proves effective

Antimicrobial agent in personal care products boosts colonization of bacteria inside human noses

Research to understand exactly how bleach kills bacteria

New injectable hydrogel repairs damaged cardiac tissue following heart attack

Novartis Institute researcher receives second annual Andrew Carnegie Prize in Mind and Brain Sciences

Dream team aims to turn pancreatic cancer into treatable disease

Researchers show Elafin protein plays key role against inflammatory reaction typical of celiac disease

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News